Literature DB >> 8968952

Tet repressor-tetracycline interaction.

P Kaszycki1, A Guz, M Drwiega, Z Wasylewski.   

Abstract

Previous studies [Wasylewski et al. (1996), J. Protein Chem. 15, 45-58] have shown that the W43 residue localized within the helix-turn-helix structure domain of Tet repressor can exist in the ground state in two conformational states. In this paper we investigate the fluorescence properties of W43 of TetR upon binding of tetracycline inducer and its chemical analogs such as anhydro- and epitetracycline. Binding of the drug inducer to the protein indicates that the W43 residue still exists in two conformational states; however, its environment changes drastically, as can be judged by the changes in fluorescence parameters. The FQRS (fluorescence-quenching-resolved spectra) method was used to decompose the total emission spectrum. The resolved spectra exhibit maxima of fluorescence at 346 and 332 nm and the component quenchable by KI (346 nm) is shifted 9 nm toward the blue side of the spectrum upon inducer binding. The observed shift does not result from the changes in the exposure of W43, since the bimolecular quenching rate constant remains the same and is equal to about 2.7 x 10(9) M-1 sec-1. The binding of tetracycline leads to drastic decrease of the W43 fluorescence intensity and increase of the tetracycline intensity as well as the decrease of fluorescence lifetime, especially of the W43 component characterized by the emission at 332 nm. The observed energy transfer from W43 to tetracycline is more efficient for the state characterized by the fluorescence emission at 332 nm (88%) than for the component quenchable by iodide (53%). Tetracycline and several of its derivatives were also used to observe how chemical modifications of the hydrophilic groups in tetracycline influence the mechanism of binding of the antibiotic to Tet repressor. By use of pulsed-laser photoacoustic spectroscopy it is shown that the binding of tetracyclines to Tet repressor leads to significant increase of tetracycline fluorescence quantum yields. Steady-state fluorescence quenching of tetracycline analogs in complexes with Tet repressor using potassium iodide as a quencher allowed us to determine the dependence of the exposure of bound antibiotic on the modifications of hydrophilic substituents of tetracycline. Circular dichroism studies of the TetR-[Mg.tc]+ complex do not indicate dramatic changes in the secondary structure of the protein; however, the observed small decrease in the TetR helicity may occur due to partial unfolding of the DNA recognition helix of the protein. The observed changes may play an important role in the process of induction in which tetracycline binding results in the loss of specific DNA binding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968952     DOI: 10.1007/bf01886743

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  24 in total

1.  Red-edge excitation fluorescence measurements of several two-tryptophan-containing proteins.

Authors:  Z Wasylewski; H Kołoczek; A Waśniowska; K Slizowska
Journal:  Eur J Biochem       Date:  1992-05-15

2.  Fluorescence-quenching-resolved spectroscopy of proteins.

Authors:  Z Wasylewski; H poloczek; A Wasniowska
Journal:  Eur J Biochem       Date:  1988-03-15

Review 3.  Time-resolved fluorescence of proteins.

Authors:  J M Beechem; L Brand
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Fluorescence quenching studies of Trp repressor using single-tryptophan mutants.

Authors:  Z Blicharska; Z Wasylewski
Journal:  J Protein Chem       Date:  1995-11

5.  Tryptophan in alpha-helix 3 of Tet repressor forms a sequence-specific contact with tet operator in solution.

Authors:  D Hansen; W Hillen
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

6.  Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor.

Authors:  J Degenkolb; M Takahashi; G A Ellestad; W Hillen
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

7.  A fluorescence study of Tn10-encoded tet repressor.

Authors:  Z Wasylewski; P Kaszycki; M Drwiega
Journal:  J Protein Chem       Date:  1996-01

Review 8.  Mechanisms underlying expression of Tn10 encoded tetracycline resistance.

Authors:  W Hillen; C Berens
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

9.  Structural analysis of the operator binding domain of Tn10-encoded Tet repressor: a time-resolved fluorescence and anisotropy study.

Authors:  M Chabbert; W Hillen; D Hansen; M Takahashi; J A Bousquet
Journal:  Biochemistry       Date:  1992-02-25       Impact factor: 3.162

10.  Determination of the equilibrium association constant between Tet repressor and tetracycline at limiting Mg2+ concentrations: a generally applicable method for effector-dependent high-affinity complexes.

Authors:  M Takahashi; J Degenkolb; W Hillen
Journal:  Anal Biochem       Date:  1991-12       Impact factor: 3.365

View more
  5 in total

1.  Fluorescence and phosphorescence study of Tet repressor-operator interaction.

Authors:  S Kuszaj; P Kaszycki; Z Wasylewski
Journal:  J Protein Chem       Date:  1999-02

2.  Fluorescence lifetimes of tryptophan: structural origin and relation with So --> 1Lb and So --> 1La transitions.

Authors:  Jihad René Albani
Journal:  J Fluoresc       Date:  2009-06-16       Impact factor: 2.217

3.  Origin of tryptophan fluorescence lifetimes part 1. Fluorescence lifetimes origin of tryptophan free in solution.

Authors:  J R Albani
Journal:  J Fluoresc       Date:  2013-08-04       Impact factor: 2.217

4.  The encapsulation of an amphiphile into polystyrene microspheres of narrow size distribution.

Authors:  Michal Pellach; Shlomo Margel
Journal:  Chem Cent J       Date:  2011-12-06       Impact factor: 4.215

5.  Rapid Discrimination Among Putative Mechanistic Models of Biochemical Systems.

Authors:  Jason G Lomnitz; Michael A Savageau
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.